Clinical Trial Update: Pediatric Hypothalamic Obesity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for pediatric hypothalamic obesity sponsored by Novartis, indicating the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothalamic Obesity
• Obesity

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Obesity | Phase 4 | Status: COMPLETED